DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
ILX23-7553
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vitamin D receptor agonist
ILX23-7553
×
Maximum Phase:
1
First Approval:
None
UNII:
O13QTC8612
Molecule Type:
Small molecule
Molecular Formula:
C27H38O3
Molecular Weight:
410.6
AlogP:
4.85
PSA:
60.69
HBD:
3.0
HBA:
#RotB:
3.0
Source:
TUCARESOL
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
TUCARESOL
×
Maximum Phase:
1
First Approval:
None
UNII:
JH368G5B9M
Molecule Type:
Small molecule
Molecular Formula:
C15H12O5
Molecular Weight:
272.26
AlogP:
2.48
PSA:
83.83
HBD:
2.0
HBA:
#RotB:
5.0
Source:
GAMMA-AMINOBUTYRIC ACID
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1; Epilepsy
Unknown
GAMMA-AMINOBUTYRIC ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
2ACZ6IPC6I
Molecule Type:
Small molecule
Molecular Formula:
C4H9NO2
Molecular Weight:
103.12
AlogP:
-0.19
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
3.0
Source:
PF-04776548
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
PF-04776548
×
Maximum Phase:
1
First Approval:
None
UNII:
CBR15S3HNJ
Molecule Type:
Small molecule
Molecular Formula:
C18H16FN3O3
Molecular Weight:
341.34
AlogP:
2.62
PSA:
67.59
HBD:
1.0
HBA:
#RotB:
3.0
Source:
KOSN-1724
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
KOSN-1724
×
Maximum Phase:
1
First Approval:
None
UNII:
6MUO20693U
Molecule Type:
Small molecule
Molecular Formula:
C27H39NO6
Molecular Weight:
473.61
AlogP:
4.57
PSA:
109.86
HBD:
2.0
HBA:
#RotB:
2.0
Source:
RX-5902
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RX-5902
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EXICORILANT
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
EXICORILANT
×
Maximum Phase:
1
First Approval:
None
UNII:
GTB859B7K8
Molecule Type:
Small molecule
Molecular Formula:
C26H23F4N7O3S
Molecular Weight:
589.58
AlogP:
3.23
PSA:
115.87
HBD:
0.0
HBA:
#RotB:
5.0
Source:
PROPYL GALLATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PROPYL GALLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
8D4SNN7V92
Molecule Type:
Small molecule
Molecular Formula:
C10H12O5
Molecular Weight:
212.2
AlogP:
1.37
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
3.0
Source:
KANAMYCIN A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
KANAMYCIN A
×
Maximum Phase:
1
First Approval:
None
UNII:
EQK9Q303C5
Molecule Type:
Small molecule
Molecular Formula:
C18H36N4O11
Molecular Weight:
484.5
AlogP:
-7.29
PSA:
282.61
HBD:
11.0
HBA:
#RotB:
6.0
Source:
CB-5083
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma; Neoplasms
Unknown
CB-5083
×
Maximum Phase:
1
First Approval:
None
UNII:
591IV6UL6J
Molecule Type:
Small molecule
Molecular Formula:
C24H23N5O2
Molecular Weight:
413.48
AlogP:
3.51
PSA:
95.06
HBD:
2.0
HBA:
#RotB:
5.0
Source:
PIPERAQUINE TETRAPHOSPHATE
1
Small molecule
Investigational
Unknown
Unknown
Malaria, Vivax
Unknown
PIPERAQUINE TETRAPHOSPHATE
×
Maximum Phase:
1
First Approval:
None
UNII:
IHB5WLO51Q
Molecule Type:
Small molecule
Molecular Formula:
C29H44Cl2N6O16P4
Molecular Weight:
927.5
AlogP:
5.42
PSA:
38.74
HBD:
0.0
HBA:
#RotB:
6.0
Source:
KO-947
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Mitogen-activated protein kinase; ERK1/ERK2 inhibitor
KO-947
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C21H17N5O
Molecular Weight:
355.4
AlogP:
4.17
PSA:
73.91
HBD:
2.0
HBA:
#RotB:
3.0
Source:
TRICHOSTATIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
TRICHOSTATIN
×
Maximum Phase:
1
First Approval:
None
UNII:
3X2S926L3Z
Molecule Type:
Small molecule
Molecular Formula:
C17H22N2O3
Molecular Weight:
302.37
AlogP:
2.58
PSA:
69.64
HBD:
2.0
HBA:
#RotB:
6.0
Source:
TAK-733
1
Small molecule
Investigational
Unknown
Unknown
Melanoma; Neoplasms
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
TAK-733
×
Maximum Phase:
1
First Approval:
None
UNII:
5J61HSP0QJ
Molecule Type:
Small molecule
Molecular Formula:
C17H15F2IN4O4
Molecular Weight:
504.23
AlogP:
1.07
PSA:
109.38
HBD:
3.0
HBA:
#RotB:
5.0
Source:
RG7893
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel protein type IX alpha subunit blocker
RG7893
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LISAVANBULIN
1
Small molecule
Investigational
Unknown
Unknown
Glioblastoma; Neoplasms
Unknown
LISAVANBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
5PT0QP06X5
Molecule Type:
Small molecule
Molecular Formula:
C26H29N9O3
Molecular Weight:
515.58
AlogP:
2.69
PSA:
190.77
HBD:
4.0
HBA:
#RotB:
13.0
Source:
CHS-828
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
CHS-828
×
Maximum Phase:
1
First Approval:
None
UNII:
8LAP87DNSZ
Molecule Type:
Small molecule
Molecular Formula:
C19H22ClN5O
Molecular Weight:
371.87
AlogP:
4.21
PSA:
82.33
HBD:
2.0
HBA:
#RotB:
9.0
Source:
AMMONIUM TRICHLORO(DIOXOETHYLENE-O,O'-)TELLURATE
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
AMMONIUM TRICHLORO(DIOXOETHYLENE-O,O'-)TELLURATE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C2H8Cl3NO2Te
Molecular Weight:
312.05
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
C-188-9
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
C-188-9
×
Maximum Phase:
1
First Approval:
None
UNII:
KZ3DLD11RQ
Molecule Type:
Small molecule
Molecular Formula:
C27H21NO5S
Molecular Weight:
471.53
AlogP:
5.88
PSA:
95.86
HBD:
3.0
HBA:
#RotB:
5.0
Source:
RODATRISTAT ETHYL
1
Small molecule
Investigational
Unknown
Unknown
Hypertension, Pulmonary
Tryptophan 5-hydroxylase 1 inhibitor
RODATRISTAT ETHYL
×
Maximum Phase:
1
First Approval:
None
UNII:
507FY6OL37
Molecule Type:
Small molecule
Molecular Formula:
C29H31ClF3N5O3
Molecular Weight:
590.05
AlogP:
5.57
PSA:
102.6
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PF-04937319
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Hexokinase type IV activator
PF-04937319
×
Maximum Phase:
1
First Approval:
None
UNII:
7E99B9ZM19
Molecule Type:
Small molecule
Molecular Formula:
C22H20N6O4
Molecular Weight:
432.44
AlogP:
3.38
PSA:
123.34
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ZOTATIFIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Severe Acute Respiratory Syndrome
Unknown
ZOTATIFIN
×
Maximum Phase:
1
First Approval:
None
UNII:
2EWN8Z05CN
Molecule Type:
Small molecule
Molecular Formula:
C28H29N3O5
Molecular Weight:
487.56
AlogP:
2.78
PSA:
108.07
HBD:
2.0
HBA:
#RotB:
6.0
Source:
GSK2849466
1
Small molecule
Investigational
Unknown
Unknown
Cachexia
Androgen Receptor modulator
GSK2849466
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TELINAVIR
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
HIV-1 protease inhibitor
TELINAVIR
×
Maximum Phase:
1
First Approval:
None
UNII:
IZF55EH3CG
Molecule Type:
Small molecule
Molecular Formula:
C33H44N6O5
Molecular Weight:
604.75
AlogP:
2.76
PSA:
166.75
HBD:
5.0
HBA:
#RotB:
13.0
Source:
VLX-1005
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VLX-1005
×
Maximum Phase:
1
First Approval:
None
UNII:
JKU4XCC48Y
Molecule Type:
Small molecule
Molecular Formula:
C21H19N3O4S2
Molecular Weight:
441.53
AlogP:
4.42
PSA:
100.55
HBD:
3.0
HBA:
#RotB:
7.0
Source:
TALETRECTINIB ADIPATE
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
TALETRECTINIB ADIPATE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C29H34FN5O5
Molecular Weight:
551.62
AlogP:
4.43
PSA:
77.47
HBD:
2.0
HBA:
#RotB:
7.0
Source:
8-CHLOROADENOSINE
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
8-CHLOROADENOSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
PA05MFH3I7
Molecule Type:
Small molecule
Molecular Formula:
C10H12ClN5O4
Molecular Weight:
301.69
AlogP:
-1.33
PSA:
139.54
HBD:
4.0
HBA:
#RotB:
2.0
Source:
TELRATOLIMOD
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections; Lymphoma, T-Cell, Cutaneous
Toll-like receptor 7 agonist
TELRATOLIMOD
×
Maximum Phase:
1
First Approval:
None
UNII:
16598XQ2BT
Molecule Type:
Small molecule
Molecular Formula:
C36H59N5O2
Molecular Weight:
593.9
AlogP:
9.1
PSA:
95.06
HBD:
2.0
HBA:
#RotB:
25.0
Source:
AZD-5153
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma, Large B-Cell, Diffuse
Unknown
AZD-5153
×
Maximum Phase:
1
First Approval:
None
UNII:
C7C7U6YEAO
Molecule Type:
Small molecule
Molecular Formula:
C25H33N7O3
Molecular Weight:
479.59
AlogP:
2.06
PSA:
88.33
HBD:
0.0
HBA:
#RotB:
7.0
Source:
SRX251
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vasopressin V1a receptor antagonist
SRX251
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CROLIBULIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Thyroid Neoplasms
Tubulin inhibitor
CROLIBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
9ENT43KY91
Molecule Type:
Small molecule
Molecular Formula:
C18H17BrN4O3
Molecular Weight:
417.26
AlogP:
2.85
PSA:
129.54
HBD:
3.0
HBA:
#RotB:
3.0
Source:
DS-3078A
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma
Serine/threonine-protein kinase mTOR inhibitor
DS-3078A
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FEDOVAPAGON
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FEDOVAPAGON
×
Maximum Phase:
1
First Approval:
None
UNII:
VX2GBO4I0V
Molecule Type:
Small molecule
Molecular Formula:
C27H34N4O3
Molecular Weight:
462.59
AlogP:
3.74
PSA:
72.96
HBD:
1.0
HBA:
#RotB:
4.0
Source:
AZD-7687
1
Small molecule
Investigational
Unknown
Unknown
Obesity
Unknown
AZD-7687
×
Maximum Phase:
1
First Approval:
None
UNII:
6QTJ9P2NYT
Molecule Type:
Small molecule
Molecular Formula:
C21H25N3O3
Molecular Weight:
367.45
AlogP:
3.61
PSA:
106.17
HBD:
2.0
HBA:
#RotB:
5.0
Source:
ROLUPERIDONE HYDROCHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Unknown
ROLUPERIDONE HYDROCHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
WFL7TF8DTP
Molecule Type:
Small molecule
Molecular Formula:
C22H28ClFN2O4
Molecular Weight:
438.93
AlogP:
3.38
PSA:
40.62
HBD:
0.0
HBA:
#RotB:
5.0
Source:
1
2
…
59
60
61
62
63
64
65
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA